207 related articles for article (PubMed ID: 22692316)
1. [Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes].
Li AF; Shen GL; Jiao SY; Li H; Wang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):431-6. PubMed ID: 22692316
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of metabolic kinetics and reaction phenotyping of ligustrazin by using liver microsomes and recombinant human enzymes].
Tan Y; Zhuang XM; Shen GL; Li H; Gao Y
Yao Xue Xue Bao; 2014 Mar; 49(3):374-9. PubMed ID: 24961110
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
5. Effect of Saccharolactone on CYP-mediated Metabolism of Xenobiotics.
Behera D; Jain P; Kurawattimath V; Gowda N
Drug Metab Bioanal Lett; 2023; 16(2):121-132. PubMed ID: 37612873
[TBL] [Abstract][Full Text] [Related]
6. Metabolic detoxification of bakuchiol is mediated by oxidation of CYP 450s in liver microsomes.
Hu XJ; Zhang YB; Zhao ZJ; Zhang L; Wang Q; Yang XW
Food Chem Toxicol; 2018 Jan; 111():385-392. PubMed ID: 29180062
[TBL] [Abstract][Full Text] [Related]
7. HLM chip - A microfluidic approach to study the mechanistic basis of cytochrome P450 inhibition using immobilized human liver microsomes.
Pihlaja T; Kiiski I; Sikanen T
Eur J Pharm Sci; 2024 Jun; 197():106773. PubMed ID: 38641124
[TBL] [Abstract][Full Text] [Related]
8. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
Nielsen LM; Holm NB; Olsen L; Linnet K
Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos.
Tang J; Cao Y; Rose RL; Hodgson E
Chem Biol Interact; 2002 Oct; 141(3):229-41. PubMed ID: 12385721
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.
Polasek TM; Miners JO
Br J Clin Pharmacol; 2008 Jan; 65(1):87-97. PubMed ID: 17662092
[TBL] [Abstract][Full Text] [Related]
12. Methoxsalen as an in vitro phenotyping tool in comparison with 1-aminobenzotriazole.
Palacharla RC; Molgara P; Panthangi HR; Boggavarapu RK; Manoharan AK; Ponnamaneni RK; Ajjala DR; Nirogi R
Xenobiotica; 2019 Feb; 49(2):169-176. PubMed ID: 29382249
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhetinic acid might increase the nephrotoxicity of bakuchiol by inhibiting cytochrome P450 isoenzymes.
Li A; Ma N; Zhao Z; Yuan M; Li H; Wang Q
PeerJ; 2016; 4():e2723. PubMed ID: 27904813
[TBL] [Abstract][Full Text] [Related]
14. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
Tang J; Amin Usmani K; Hodgson E; Rose RL
Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
[TBL] [Abstract][Full Text] [Related]
18. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
Usmani KA; Chen WG; Sadeque AJ
Drug Metab Dispos; 2012 Apr; 40(4):761-71. PubMed ID: 22266842
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.
Emoto C; Murase S; Sawada Y; Iwasaki K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):351-7. PubMed ID: 16272753
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of 4, 5-dimethoxycanthin-6-one by human liver microsomes and its inhibition on human CYP1A2.
Miao X; You J; Wang J; Chen Y
Life Sci; 2017 Dec; 190():46-51. PubMed ID: 28962866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
